Identification and functional analysis of a novel G310D variant in the insulin‐like growth factor 1 receptor (IGF1R) gene associated with type 2 diabetes in American Indians. Issue 4 (25th March 2018)

• Record Type: Journal Article
• Authors: Muller, Yunhua L.; Skelton, Graham; Piaggi, Paolo; Chen, Peng; Nair, Anup; Kobes, Sayuko; Hsueh, Wen‐Chi; Knowler, William C.; Hanson, Robert L.; Baier, Leslie J.; Bogardus, Clifton
• Is Part Of: Diabetes/metabolism research and reviews. Volume 34:Issue 4(2018)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2018-03-25
• Subjects: American Indian -- association analysis -- G310D variant -- IGF1R -- type 2 diabetes; Diabetes -- Periodicals; Metabolism -- Periodicals; 616.642
• DOI: 10.1002/dmrr.2994
• Languages: English
• ISSNs: 1520-7552

Abstract

Abstract: Aims: Insulin‐like growth factor 1 receptor (IGF1R) is involved in cell growth and glucose homeostasis. In the current study, the IGF1R locus was analysed as a candidate gene for type 2 diabetes (T2D) in American Indians. Materials and methods: Whole genome sequence data from 335 American Indians identified 3 novel missense variants in IGF1R . The associations of IGF1R variants with T2D, age of T2D onset and birth weight were analysed in a population‐based sample of 7701 American Indians. Results: A novel glycine‐to‐aspartic acid substitution (G310D) in IGF1R was identified, which associated with T2D in a sex‐specific manner ( P sex interaction = 0.02). In women, the aspartic acid (D) allele (frequency = 0.034) was associated with increased risk for T2D (n = 4292, P = 2.0 × 10 −5 adjusted for age, birth year, and the first 5 genetic principal components; odds ratio [OR] = 2.23 [1.54‐3.23] per risk allele) and an earlier age of T2D onset (n = 4292, P = 2 × 10 −4, hazard rate ratio = 1.45 [1.20‐1.75], P sex interaction = 0.05). Female carriers of the D‐allele also had lower birth weight (n = 1313, β = −163 g, P = .006, P sex interaction = 0.008). Among 85 siblings discordant for G310D, carriers of the D‐allele had shorter stature as compared with carriers of the G‐allele (β = −1.6 cm, P = .001, within family model). The G310D variant was functionally studied in vitro, where the D‐allele had a 22% increase ( P = .0005) in FOXO1‐induced transcriptional activity, due to decreased activation of the PI3K/AKT pathway mediated through reduced IGF1R activity. Conclusion: A unique G310D variant in IGF1R, which occurs in 6% American Indians, may impair IGF1R signalling pathways, thereby increasing the risk of T2D.